Reshma Kewalramani's Net Worth
Reshma Kewalramani's net worth is estimated to be at least $19,726,400.35 as of 05/03/2024. CoreStreet's estimation of Reshma Kewalramani's net worth is based on their sale of stock and current holding of stock.
Reshma Kewalramani is CEO at Vertex Pharmaceuticals Inc. They have executed at least 15 trades of stock as per SEC Form 4 filings. Their most recent trade was for 7,828 units of VRTX stock on 07/17/2023. Their biggest sale was on 08/15/2022 when they sold 11,689 units of Vertex Pharmaceuticals Inc stock for $3,565,846.34. They typically trade 2 times per year.
Total value of insider buys:
- $1,956,500.00
Total value of insider sells:
- $17,769,900.35
Most recent insider trade:
- July 17, 2023
Reshma Kewalramani's Insider Trading History
| Vertex Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 17, 2023 | CEO | 7,828 | $355.00 | Sell | $2,778,940.00 |
April 27, 2023 | CEO | 3,317 | $339.08 | Sell | $1,124,728.36 |
Jan. 25, 2023 | CEO | 10,000 | $315.05 | Sell | $3,150,500.00 |
Aug. 15, 2022 | CEO | 11,689 | $305.06 | Sell | $3,565,846.34 |
June 24, 2022 | CEO | 11,689 | $291.30 | Sell | $3,405,005.70 |
Aug. 19, 2021 | CEO | 10,000 | $195.65 | Buy | $1,956,500.00 |
Feb. 25, 2020 | CMO | 3,634 | $233.45 | Sell | $848,357.30 |
Feb. 18, 2020 | CMO | 1,183 | $243.51 | Sell | $288,072.33 |
Nov. 25, 2019 | CMO | 4,692 | $219.37 | Sell | $1,029,284.04 |
Nov. 8, 2019 | CMO | 509 | $199.00 | Sell | $101,291.00 |
Oct. 30, 2019 | CMO | 3,057 | $199.00 | Sell | $608,343.00 |
Oct. 22, 2019 | CMO | 638 | $189.00 | Sell | $120,582.00 |
May 15, 2019 | CMO | 241 | $165.41 | Sell | $39,863.81 |
Feb. 19, 2019 | CMO | 1,488 | $186.94 | Sell | $278,166.72 |
Oct. 8, 2018 | CMO | 2,305 | $186.95 | Sell | $430,919.75 |